Senseonics (NYSE:SENS) Given a $1.10 Price Target at HC Wainwright

Senseonics (NYSE:SENS) has been given a $1.10 price objective by equities researchers at HC Wainwright in a report issued on Monday, June 2nd, Marketbeat reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price target indicates a potential upside of 111.54% from the company’s previous close. HC Wainwright also issued estimates for Senseonics’ Q2 2025 earnings at ($0.02) EPS, Q3 2025 earnings at ($0.02) EPS, Q4 2025 earnings at ($0.01) EPS, FY2025 earnings at ($0.07) EPS, Q1 2026 earnings at ($0.01) EPS, Q2 2026 earnings at ($0.01) EPS, Q3 2026 earnings at ($0.01) EPS, Q4 2026 earnings at ($0.01) EPS, FY2026 earnings at ($0.06) EPS, FY2027 earnings at ($0.03) EPS, FY2028 earnings at ($0.01) EPS and FY2029 earnings at $0.01 EPS.

Several other analysts also recently weighed in on SENS. Mizuho started coverage on shares of Senseonics in a research note on Thursday, April 10th. They issued an “outperform” rating and a $2.00 price target for the company. Wall Street Zen raised shares of Senseonics to a “sell” rating in a research note on Monday, May 12th.

Senseonics Stock Performance

Senseonics stock opened at $0.52 on Monday. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17. The company has a market capitalization of $340.19 million, a PE ratio of -4.00 and a beta of 0.96. The firm has a fifty day simple moving average of $0.60 and a two-hundred day simple moving average of $0.66. Senseonics has a twelve month low of $0.25 and a twelve month high of $1.40.

Hedge Funds Weigh In On Senseonics

A number of institutional investors have recently bought and sold shares of the stock. First Light Asset Management LLC bought a new position in Senseonics in the fourth quarter worth about $3,366,000. Geode Capital Management LLC raised its stake in Senseonics by 9.7% in the fourth quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company’s stock worth $3,354,000 after buying an additional 566,704 shares in the last quarter. Jane Street Group LLC raised its stake in Senseonics by 6,694.1% in the fourth quarter. Jane Street Group LLC now owns 6,118,786 shares of the company’s stock worth $3,203,000 after buying an additional 6,028,726 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in Senseonics by 4.9% in the first quarter. Charles Schwab Investment Management Inc. now owns 3,502,326 shares of the company’s stock worth $2,298,000 after buying an additional 162,628 shares in the last quarter. Finally, Renaissance Technologies LLC bought a new position in Senseonics in the fourth quarter worth about $720,000. 12.36% of the stock is owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.